Find comprehensive information on Substance Use Disorder diagnosis, including clinical documentation requirements, ICD-10-CM codes (F10-F19), DSM-5 criteria, and medical billing guidelines. Learn about substance abuse treatment, addiction medicine, behavioral health resources, and the importance of accurate coding for opioid dependence, alcohol use disorder, and other substance-related diagnoses in healthcare settings. This resource supports clinicians, coders, and healthcare professionals in proper documentation and coding for substance abuse.
Also known as
Mental and behavioral disorders due to psychoactive substance use
Covers a wide range of substance abuse disorders including alcohol, opioids, cannabis, etc.
Problem related to lifestyle
This code can be used for problems related to substance abuse like nicotine dependence.
Poisoning by, adverse effect of and underdosing of drugs
Includes complications and adverse effects from substance use, including overdoses and withdrawal.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the substance use active?
When to use each related code
| Description |
|---|
| Substance Abuse |
| Alcohol Use Disorder |
| Opioid Use Disorder |
Using unspecified substance abuse codes (e.g., F19.90) when more specific documentation is available leads to inaccurate severity and reimbursement.
Incorrectly coding remission or maintenance status (e.g., early vs. sustained, in vs. on maintenance) impacts quality reporting and treatment plans.
Overlooking or undercoding co-occurring mental health diagnoses with substance abuse impacts risk adjustment and resource allocation.
Q: What are the most effective evidence-based interventions for co-occurring substance use disorder and PTSD in a primary care setting?
A: Integrating evidence-based interventions for co-occurring substance use disorder (SUD) and post-traumatic stress disorder (PTSD) in primary care settings can significantly improve patient outcomes. Trauma-informed care is crucial, creating a safe and understanding environment. Effective interventions often involve a combination of approaches, including: 1. Screening and assessment tools like the PC-PTSD and AUDIT-C to identify both conditions. 2. Motivational interviewing and cognitive behavioral therapy (CBT) techniques adapted for integrated treatment, addressing both trauma and substance use. 3. Medication management, where appropriate, with FDA-approved medications for PTSD or SUD, considering potential drug interactions. 4. Referral to specialized care if needed, such as a mental health clinic or addiction treatment center, ensuring seamless transitions. 5. Strong emphasis on patient-centered care, involving shared decision-making and addressing individual patient needs and preferences. Explore how integrated care models can enhance treatment adherence and reduce long-term healthcare costs. Consider implementing collaborative care pathways that include primary care physicians, mental health professionals, and addiction specialists.
Q: How can I accurately differentiate between substance-induced psychosis and primary psychotic disorders during a diagnostic evaluation?
A: Differentiating between substance-induced psychosis and primary psychotic disorders, such as schizophrenia, requires a comprehensive diagnostic evaluation. A thorough clinical history, including substance use patterns, onset of psychotic symptoms, and family history of mental illness, is essential. Observe for symptoms specific to substance-induced psychosis, such as tactile hallucinations (e.g., formication) and visual hallucinations, which are less common in primary psychotic disorders. Temporal correlation between substance use and the onset or exacerbation of psychotic symptoms is a key factor. Consider the duration of psychotic symptoms after cessation of substance use; in substance-induced psychosis, symptoms typically resolve within weeks to months, whereas primary psychotic disorders persist. Neuropsychological testing can help identify cognitive deficits specific to each condition. Urine drug screens, blood tests, and imaging studies (e.g., MRI) can rule out other medical conditions. Learn more about validated assessment tools for psychosis and substance use to enhance diagnostic accuracy. Consider implementing standardized assessment protocols to ensure consistent and reliable evaluations.
Patient presents today with concerns regarding substance use, prompting an evaluation for substance abuse disorder. The patient reports a history of [Substance Name] use, escalating in frequency and quantity over the past [Duration]. They describe [Specific pattern of use, e.g., daily use, binge use on weekends]. Patient acknowledges experiencing [Symptoms related to substance abuse, e.g., cravings, withdrawal symptoms, tolerance, inability to cut down]. These symptoms have resulted in negative consequences impacting [Areas of life affected, e.g., work, relationships, finances, health]. Patient reports [Previous attempts to quit or control use, if any]. Family history is significant for [Family history of addiction, if any]. Mental status examination reveals [Observations related to substance use, e.g., anxious affect, psychomotor agitation, clear sensorium]. Physical examination findings include [Relevant physical findings, e.g., elevated blood pressure, track marks]. Urine drug screen ordered. Based on the patient's self-reported history, clinical presentation, and reported impact on their life, a diagnosis of [Specific Substance Use Disorder, including severity e.g., Moderate Opioid Use Disorder] is made, consistent with DSM-5 criteria. Differential diagnoses considered include [Relevant differential diagnoses, e.g., mood disorder, anxiety disorder]. Treatment plan includes [Specific interventions, e.g., referral to addiction specialist, initiation of medication-assisted treatment, individual therapy, support groups]. Patient education provided regarding the nature of addiction, treatment options, relapse prevention strategies, and community resources. Risks and benefits of treatment options discussed. Patient expressed understanding and agreed to the proposed treatment plan. Follow-up scheduled in [Timeframe]. ICD-10 code [Relevant ICD-10 code] and CPT codes [Relevant CPT codes for evaluation and management] will be used for billing and coding purposes.